Besides, a prior investigation has demonstrated that Entrectinib can suppress vimentin and N-cadherin expression in mice with bleomycin-induced pulmonary fibrosis (Miao et al. 2022). The gene discussed is VIM; the disease is pulmonary fibrosis.